Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-24-004792
Filing Date
2024-04-05
Accepted
2024-04-05 17:30:23
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20240405xdefa14a.htm DEFA14A 16233
2 GRAPHIC tmb-20240405xdefa14a_bg001.jpg GRAPHIC 167901
3 GRAPHIC tmb-20240405xdefa14a_bg002.jpg GRAPHIC 171725
  Complete submission text file 0001558370-24-004792.txt   485384
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

EIN.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35366 | Film No.: 24827587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)